quant Healthcare Fund holds 27 instruments (99.42% equity), led by GlaxoSmithKline Pharmaceuticals Limited (9.69%), Divi's Laboratories Limited (9.63%) and Aurobindo Pharma Limited (9.61%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of quant Healthcare Fund, managed by quant Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 27 instruments with an equity allocation of 99.42%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
quant Healthcare Fund's top 10 holdings account for 84.88% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 90.22% of net assets, spread across 4 sectors in total. Since its 31 August 2026 disclosure, the fund added 7 new positions and exited 2 positions, with Strides Pharma Science Limited seeing the largest move (+6.59pp to 9.04%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Strides Pharma Science Limited | 2.45% → 9.04% | ▲ +6.59 |
| Aurobindo Pharma Limited | 5.18% → 9.61% | ▲ +4.43 |
| Stock | Weight | Change |
|---|---|---|
| Alivus Life Sciences Limited | 8.08% → 6.21% | ▼ -1.87 |
| Pfizer Limited | 8.83% → 7.37% | ▼ -1.46 |
| GlaxoSmithKline Pharmaceuticals Limited | 10.58% → 9.69% | ▼ -0.89 |
| Zydus Wellness Limited | 5.64% → 4.9% | ▼ -0.74 |
| IPCA Laboratories Limited | 6.22% → 5.98% | ▼ -0.24 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
| # | Holding | Sector | % to NAV |
|---|---|---|---|
| 1 | TREPS DEPO 10other | — | 26.57% |
| 2 | GlaxoSmithKline Pharmaceuticals Limited | Healthcare | 9.69% |
| 3 | Divi's Laboratories Limited | Healthcare | 9.63% |
| 4 | Aurobindo Pharma Limited | Healthcare | 9.61% |
| 5 | Zydus Lifesciences Limited | Healthcare | 9.39% |
| 6 | Glenmark Pharmaceuticals Limited | Healthcare | 9.34% |
| 7 | Strides Pharma Science Limited | Healthcare | 9.04% |
| 8 | Torrent Pharmaceuticals Limited | Healthcare | 8.62% |
| 9 | Pfizer Limited | Healthcare | 7.37% |
| 10 | Alivus Life Sciences Limited | Healthcare | 6.21% |
| 11 | IPCA Laboratories Limited | Healthcare | 5.98% |
| 12 | Zydus Wellness Limited | Consumer Staples | 4.9% |
| 13 | Colgate Palmolive (India) Limited | Consumer Staples | 3.45% |
| 14 | Natco Pharma Limited | Healthcare | 3.01% |
| 15 | Dr. Reddy's Laboratories Limited | Healthcare | 2.33% |
| 16 | 91 Days Treasury Billstbill | — | 0.71% |
| 17 | 91 Days Treasury Billtbill | — | 0.7% |
| 18 | 91 Days Treasury Billsbond | — | 0.7% |
| 19 | 91 Days Treasury Billstbill | — | 0.7% |
| 20 | 91 Days Treasury Billtbill | — | 0.7% |
| 21 | 91 Days Treasury Billstbill | — | 0.7% |
| 22 | 91 Days Treasury Billstbill | — | 0.7% |
| 23 | 91 Days Treasury Billsbond | — | 0.7% |
| 24 | 91 Days Treasury Billsbond | — | 0.7% |
| 25 | LG Electronics India Limited | Consumer Discretionary | 0.59% |
| 26 | Sumitomo Chemical India Limited | Materials | 0.26% |
| 27 | NCA-NET CURRENT ASSETSother | — | -32.3% |
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: quant Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.